Summary
Different prevalences of chlorpropamide alcohol flushing (CPAF) have been reported by different authors in either type I or type II diabetics or in normal subjects and this could be due to different methodological approaches or to different criteria of evaluation of CPAF. Previous studies in small series of patients have also suggested the existence of an association between type I diabetes and the fast acetylator phenotype (AP). The first aim of this study was to find reliable criteria for the assessment of CPAF. The second was to evaluate the prevalence of CPAF and of AP in a large series of type I and type II diabetics; and the third was to evaluate possible associations of CPAF and AP. AP and CPAF were evaluated separately in 256 diabetics (110 with type I and 146 with type II diabetes) and in 183 diabetics (74 with type I and 109 with type II diabetes), respectively. In 156 of these subjects, the two markers were evaluated together. The occurrence of CPAF was studied by subjective and objective assessment and by thermographic recording; CPAF was quantified by the differential value of skin temperature increase [Δ T(C-P)] and by the value of differential speed of ascent, expressed in angle-degrees [Δ a(C-P)], after treatment with placebo and with chlorpropamide. The fast AP was more frequent in type I than in type II diabetics, was not related to family history of diabetes, sex of the patients, age at onset and duration of diabetes or metabolic control. The most reliable assessment of CPAF was represented by thermographic recording of speed of ascent of skin temperature. CPAF was more frequent in females than in males, more frequent in diabetics than in healthy controls, similarly frequent in type I and in type II diabetes and showed no relationship with family history of diabetes, age at onset, duration of diabetes or metabolic control. An association between fast AP and CPAF was found in type II, but not in type I diabetics: fast acetylators were more frequently CPAF-positive, while slow acetylators were more frequently CPAF-negative. In addition, a linear relationship was found between rate of acetylation and speed of ascent of facial skin temperature after chlorpropamide and alcohol in type II diabetics, not in type I diabetics. The meaning of this association is not clear and deserves further investigations.
Similar content being viewed by others
References
Barnett A. H., Gonzalez-Auvert C., Pyke D. A., Saunders J. B., Williams R., Dickenson C. J., Rawlins M. D.: Blood concentrations of acetaldehyde during the chlorpropamide-alcohol flush — Brit. med. J.ii, 939, 1981.
Barnett A. H., Spiliopoulos A. J., Pyke D. A.: Blockade of chlorpropamide-alcohol flushing by indomethacin suggests an association between prostaglandins and diabetic vascular complications — Lancetii, 164, 1980.
Bodansky H. J., Drury P. L., Cudworth A. G., Price-Evans D. A.: Acetylator phenotypes and type I (insulin-dependent) diabetics with microvascular disease — Diabetes30, 907, 1981.
De Silva N. E., Tunbridge W. M. G.: Chlorpropamide alcohol flushing (CPAF) in noninsulin dependent diabetics (NIDDs) — Diabetologia19, 269, 1980; abstract # 101.
De Silva N. E., Tunbridge W. M. G., Alberti K. G. M. M.: Low incidence of chlorpropamide-alcohol flushing in diet-treated, non-insulin dependent diabetes — Lanceti, 128, 1981.
Groop L., Koskimies S., Tolppanen E. M.: Characterization of patients with chlorpropamide-alcohol flush — Acta med. scand.215, 141, 1984.
Jefferys D. B., Strakosch C. R.: Chlorpropamide alcohol flush. One or many? — Diabetologia19, 286, 1980; abstract # 194.
Jerntorp P.: Chlorpropamide alcohol flush and aldehyde dehydrogenase activity in relation to late complications in diabetes mellitus. Doctoral Dissertation, Lund University, 1985.
Johnston C., Wiles P. G., Pyke D. A.: Chlorpropamide-alcohol flush: the case in favour — Diabetologia26, 1, 1984.
Köbberling J., Bengsch N., Brücgeboes B., Schwarck H., Tillil H., Weber M.: The chlorpropamide alcohol flush. Lack of specificity for familial non-insulin dependent diabetes — Diabetologia19, 359, 1980.
Köbberling J., Weber M.: Facial flush after chlorpropamide-alcohol and enkephalin — Lanceti, 583, 1980.
Leslie R. D. G., Pyke D. A.: Chlorpropamide alcohol flushing: a dominantly inherited trait associated with diabetes — Brit. med. J.ii, 1519, 1978.
Leslie R. D. G., Pyke D. A., Stubbs W. A.: Sensitivity to enkephalin as a cause of non-insulin dependent diabetes — Lanceti, 341, 1979.
Micossi P., Mannucci P. M., Librenti M. C., Raggi U., D’Angelo A., Corallo S., Garimberti B., Bozzini S., Malagco E.: Chlorpropamide alcohol flushing in non-insulin dependent diabetes: prevalence of small and large vessel disease and of risk factors for angiopathy — Acta diabetol. lat.19, 141, 1982.
Öhlin H., Jerntorp P., Bergstrom B., Almér L. O.: Chlorpropamide alcohol flushing, acetaldehyde dehydrogenase activity, and diabetic complications — Brit. med. J.ii, 838, 1982.
Pontiroli A. E., De Pasqua A., Colombo R., Ricordi C., Pozza G.: Characterization of the chlorpropamide-alcohol-flush in patients with type I and type II diabetes — Acta diabetol. lat.20, 117, 1983.
Pontiroli A. E., Mosca A., De Pasqua A., Alcini D., Pozza G.: The fast acetylator phenotype in diabetes mellitus: abnormal prevalence and association with the ABO blood groups — Diabetologia27, 235, 1984.
Price-Evans D. A.: An improved and simplified method of detecting the acetylator phenotype — J. med. Genet.6, 405, 1969.
Price-Evans D. A., Manley K. A., Mc Kusick V. A.: Genetic control of isoniazid metabolism in man — Brit. med. J.ii, 485, 1960.
Price-Evans D. A., White T. A.: Human acetylation polymorphism — J. Lab. clin. Med.63, 394, 1964.
Pyke D. A., Leslie R. D. G.: Chlorpropamide-alcohol flushing: a definition of its relation to non-insulin dependent diabetes — Brit. med. J.ii, 1521, 1978.
Radder J. K., Box M. C. J. G., Lemkes H. H. P. J.: Facial skin temperature and the chlorpropamide-alcohol flush in diabetics — Lancetii, 1037, 1980.
Schlichtkrull J., Munck O., Jerslid M.: The M-value, an index of blood sugar control in diabetics — Acta med. scand.177, 95, 1965.
Signorelli S.: Tolerance for alcohol in patients on chlorpropamide — Ann. N.Y. Acad. Sci.74, 900, 1959.
Tang Fui Ng S., Keen H., Jarrett R. J., Strakosch C., Murrells T., Marsden P., Stott R.: Epidemiological study of prevalence of chlorpropamide alcohol flushing in insulin dependent diabetics, non-insulin dependent diabetics, and non-diabetics — Brit. med. J.287, 1509, 1983.
Varley M.: Practical clinical biochemistry. Heinemann Medical Books, London, 1954; p. 632.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bonisolli, L., Pontiroli, A.E., Pasqua, A.D. et al. Association between chlorpropamide-alcohol flushing and fast acetylator phenotype in type I and type II diabetes. Acta diabet. lat 22, 305–315 (1985). https://doi.org/10.1007/BF02624749
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02624749